Covered recipient · General Payments record
JORGE L MALOUF
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,880.31
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,001.78 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $250.00 | 2 |
| Tarsus Pharmaceuticals, Inc. | $202.81 | 3 |
| Harrow Eye, LLC | $155.52 | 5 |
| Alcon Laboratories Inc | $150.00 | 1 |
| Bausch & Lomb Americas Inc. | $148.89 | 2 |
| Dompe US, Inc. | $50.36 | 2 |
| Amgen Inc. | $44.20 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949209 | CMS |
| ABBVIE INC. | $125.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949213 | CMS |
| Alcon Vision LLC | $150.00 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110662973 | CMS |
| Amgen Inc. | $23.71 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111642044 | CMS |
| Amgen Inc. | $20.49 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111642046 | CMS |
| Bausch & Lomb Americas Inc. | $23.90 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140375705 | CMS |
| Bausch & Lomb Americas Inc. | $124.99 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140375703 | CMS |
| Dompe US, Inc. | $29.63 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151407201 | CMS |
| Dompe US, Inc. | $20.73 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151407199 | CMS |
| Harrow Eye, LLC | $125.00 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145608838 | CMS |
| Harrow Eye, LLC | $4.16 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145608840 | CMS |
| Harrow Eye, LLC | $0.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145608842 | CMS |
| Harrow Eye, LLC | $22.70 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145608844 | CMS |
| Harrow Eye, LLC | $2.72 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145608846 | CMS |
| Tarsus Pharmaceuticals, Inc. | $137.25 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139114607 | CMS |
| Tarsus Pharmaceuticals, Inc. | $32.94 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139114609 | CMS |
| Tarsus Pharmaceuticals, Inc. | $32.62 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139114611 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.